or Try an Advanced Search...

    Technical Analysis for RNA - Avidity Biosciences, Inc.

    Grade Last Price % Change Price Change
    A 41.28 1.05% 0.43
    RNA closed up 1.05 percent on Monday, July 1, 2024, on 75 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical RNA trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing High Bullish 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    New 52 Week Closing High Bullish 1.05%
    Pocket Pivot Bullish Swing Setup 1.05%
    Volume Surge Other 1.05%
    Older End-of-Day Signals for RNA ...

       Recent Intraday Alerts

    Alert Time
    Up 1% about 4 hours ago
    Possible NR7 about 6 hours ago
    Possible Inside Day about 6 hours ago
    Down 1% about 10 hours ago
    Up 2% 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    RNA Chart by TradingView
    Basic chart:

    Profile

    Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Treatment Of Cancer Pharmaceutical Products Biopharmaceutical Products

    Is RNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 (RNA) - Analyzing Avidity Biosciences's Short Interest
    Jun 20 Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day
    Jun 19 Estimating The Intrinsic Value Of Avidity Biosciences, Inc. (NASDAQ:RNA)
    Jun 17 Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
    Jun 16 Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
    Jun 14 Avidity Biosciences: Muscular Dystrophy Breakthrough Propels To A 'Buy' Upgrade
    Jun 14 Avidity Biosciences to Participate in Upcoming Investor Conference
    Jun 14 Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
    Jun 14 Avidity Biosciences raises $400M via stock offering
    Jun 14 Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
    See more RNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 42.0
    52 Week Low 4.825
    Average Volume 1,576,748
    200-Day Moving Average 16.54
    50-Day Moving Average 30.01
    20-Day Moving Average 35.25
    10-Day Moving Average 39.57
    Average True Range 2.12
    RSI (14) 74.87
    ADX 38.53
    +DI 37.37
    -DI 11.84
    Chandelier Exit (Long, 3 ATRs) 35.64
    Chandelier Exit (Short, 3 ATRs) 31.66
    Upper Bollinger Bands 47.04
    Lower Bollinger Band 23.45
    Percent B (%b) 0.76
    BandWidth 66.93
    MACD Line 3.47
    MACD Signal Line 3.16
    MACD Histogram 0.305
    Fundamentals Value
    Market Cap 3.28 Billion
    Num Shares 79.4 Million
    EPS -3.00
    Price-to-Earnings (P/E) Ratio -13.76
    Price-to-Sales 113.02
    Price-to-Book 2.05
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 43.31
    Resistance 3 (R3) 43.12 42.26 42.97
    Resistance 2 (R2) 42.26 41.74 42.35 42.85
    Resistance 1 (R1) 41.77 41.43 42.02 41.96 42.74
    Pivot Point 40.91 40.91 41.03 41.00 40.91
    Support 1 (S1) 40.42 40.39 40.67 40.61 39.82
    Support 2 (S2) 39.56 40.08 39.65 39.71
    Support 3 (S3) 39.07 39.56 39.59
    Support 4 (S4) 39.26